Moleculin Biotech, Inc. (MBRX)
0.7659
+0.02
(+2.11%)
USD |
NASDAQ |
Sep 09, 13:58
Moleculin Biotech 1 Year Total Returns (Daily) : -92.29% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -92.29% |
| September 04, 2026 | -92.51% |
| September 03, 2026 | -92.80% |
| September 02, 2026 | -92.68% |
| September 01, 2026 | -93.37% |
| August 31, 2026 | -93.43% |
| August 28, 2026 | -93.39% |
| August 27, 2026 | -95.46% |
| August 26, 2026 | -95.60% |
| August 25, 2026 | -95.75% |
| August 24, 2026 | -95.71% |
| August 21, 2026 | -96.02% |
| August 20, 2026 | -95.79% |
| August 19, 2026 | -96.16% |
| August 18, 2026 | -95.98% |
| August 17, 2026 | -96.44% |
| August 14, 2026 | -96.22% |
| August 13, 2026 | -96.61% |
| August 12, 2026 | -96.85% |
| August 11, 2026 | -97.14% |
| August 10, 2026 | -97.45% |
| August 07, 2026 | -97.58% |
| August 06, 2026 | -97.65% |
| August 05, 2026 | -97.72% |
| August 04, 2026 | -97.61% |
| Date | Value |
|---|---|
| August 03, 2026 | -97.44% |
| July 31, 2026 | -97.45% |
| July 30, 2026 | -94.26% |
| July 29, 2026 | -92.39% |
| July 28, 2026 | -84.08% |
| July 27, 2026 | -84.55% |
| July 24, 2026 | -86.69% |
| July 23, 2026 | -88.26% |
| July 22, 2026 | -89.17% |
| July 21, 2026 | -89.28% |
| July 20, 2026 | -89.33% |
| July 17, 2026 | -89.95% |
| July 16, 2026 | -86.44% |
| July 15, 2026 | -85.30% |
| July 14, 2026 | -85.65% |
| July 13, 2026 | -83.93% |
| July 10, 2026 | -82.92% |
| July 09, 2026 | -82.94% |
| July 08, 2026 | -81.82% |
| July 07, 2026 | -76.13% |
| July 06, 2026 | -71.76% |
| July 02, 2026 | -69.61% |
| July 01, 2026 | -66.84% |
| June 30, 2026 | -63.03% |
| June 29, 2026 | -54.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |
| Anika Therapeutics, Inc. | 135.3% |
| Savara, Inc. | 43.64% |
| Vericel Corp. | 17.64% |